Clinical decision support
The partnership aims to raise patient safety, boost cost-effectiveness and improve care by combining Glytec's software with Roche's system.
The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine will utilize CancerIQ’s AI platform for personalized risk assessments and advanced early detection.
The company's FDA-cleared autonomous ultrasound imaging system uses a probe to allow for imaging in resource-limited environments to support trauma medicine.
Also, MediBuddy in India has developed an AI to detect fraudulent claims.
The company will use the funds to expand the adoption of its surgical software and fund mergers and acquisitions.
It is also solidifying its presence in the United States market through Cedars-Sinai's backing.
The company's purchase will allow it to expand into the U.K. market.
The mobile app-based AI has 87% accuracy in identifying Alzheimer's disease.
Powered by AI, it has over 80% accuracy in detecting valvular heart disease.
Also, ezCaretech is integrating predictive AI into its EHR offering.